Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals

Psychopharmacology

Volumn 224, Issue 4, 2012, Pages 501-509

  Chamberlain, Samuel R ^a,b,c   Mogg, Karin ^d   Bradley, Brendan P ^d   Koch, Annelize ^a   Dodds, Chris M ^a   Tao, Wenli X ^a   Maltby, Kay ^a   Sarai, Bhopinder ^a   Napolitano, Antonella ^a   Richards, Duncan B ^a   Bullmore, Edward T ^a,b,c   Nathan, Pradeep J ^a,b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Binge eating; Cognition; Impulsivity; Mu; Mu opioid; Opiate; Opioid

Indexed keywords

GSK 1521498; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATTENTION; BINGE EATING DISORDER; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL TASK; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STIMULUS RESPONSE; TREATMENT OUTCOME; WORKING MEMORY;

ADOLESCENT; ADULT; ATTENTION; BINGE-EATING DISORDER; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; NARCOTIC ANTAGONISTS; NEUROPSYCHOLOGICAL TESTS; RECEPTORS, OPIOID, MU; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRIAZOLES; YOUNG ADULT;

EID: 84871611910     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2778-x     Document Type: Article

References (68)

1. Anton RF, Drobes DJ et al (2004) Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology (Berl) 173(1-2):32-40
2. Anton RF, O'Malley SS et al (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295(17):2003-2017
3. Apfelbaum M, Mandenoff A (1981) Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet. Pharmacol Biochem Behav 15(1):89-91
4. Asad N, Karmaliani R et al (2010) Prevalence of suicidal thoughts and attempts among pregnant Pakistani women. Acta Obstet Gynecol Scand 89(12):1545-1551
5. Avena NM, Bocarsly ME et al (2011) Overlaps in the nosology of substance abuse and overeating: the translational implications of "food addiction". Curr Drug Abuse Rev 4(3):133-139
6. Beck AT, Beamesderfer A (1974) Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatr 7:151-169
7. Beck AT, Ward CH et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
8. Bello NT, Patinkin ZW et al (2011) Opioidergic consequences of dietary-induced binge eating. Physiol Behav 104(1):98-104
9. Bencherif B, Guarda AS et al (2005) Regional mu-opioid receptor binding in insular cortex is decreased in bulimia nervosa and correlates inversely with fasting behavior. J Nucl Med 46(8):1349-1351
10. Berrendero F, Robledo P et al (2010) Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci Biobehav Rev 35(2):220-231
11. Berridge KC (2009) 'Liking' and 'wanting' food rewards: brain substrates and roles in eating disorders. Physiol Behav 97(5):537-550
12. Brignell C, Griffiths T et al (2009) Attentional and approach biases for pictorial food cues. Influence of external eating. Appetite 52(2):299-306
13. Calitri R, Pothos EM et al (2010) Cognitive biases to healthy and unhealthy food words predict change in BMI. Obesity (Silver Spring) 18(12):2282-2287
14. Callicott JH, Ramsey NF et al (1998) Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 18(3):186-196
15. Chamberlain SR, Sahakian BJ (2007) The neuropsychiatry of impulsivity. Curr Opin Psychiatry 20(3):255-261
16. Chamberlain, SR, Robbins TW et al (2010) Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biol Psychiatry
17. Cohen RM, Cohen MR et al (1983) High-dose naloxone affects task performance in normal subjects. Psychiatry Res 8(2):127-136
18. Colantuoni C, Schwenker J, McCarthy J et al (2001) Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport 12:3549-3552
19. Corwin RL, Avena NM et al (2011) Feeding and reward: perspectives from three rat models of binge eating. Physiol Behav 104(1):87-97
20. Cox WM, Fadardi JS et al (2006) The addiction-stroop test: theoretical considerations and procedural recommendations. Psychol Bull 132(3):443-476
21. Davis C, Carter JC (2009) Compulsive overeating as an addiction disorder. a review of theory and evidence. Appetite 53(1):1-8
22. Davis C, Zai C et al (2011) Opiates, overeating and obesity: a psychogenetic analysis. Int J Obes (Lond) 35(10):1347-1354
23. Evans RG, Ludbrook J (1990) Effects of mu-opioid receptor agonists on circulatory responses to simulated haemorrhage in conscious rabbits. Br J Pharmacol 100(3):421-426
24. Fernandez-Serrano MJ, Perez-Garcia M et al (2011) What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neurosci Biobehav Rev 35(3):377-406
25. Fulton S (2010) Appetite and reward. Front Neuroendocrinol 31(1):85-103
26. Giuliano C, Robbins TW, Nathan PJ, Bullmore ET, Everitt BJ (2012) Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacol (in press)
27. Gladis MM, Wadden TA et al (1998) A comparison of two approaches to the assessment of binge eating in obesity. Int J Eat Disord 23(1):17-26
28. Goodman A (2008) Neurobiology of addiction. An integrative review. Biochem Pharmacol 75(1):266-322
29. Gormally J, Black S et al (1982) The assessment of binge eating severity among obese persons. Addict Behav 7(1):47-55
30. Grant JE, Brewer JA et al (2006) The neurobiology of substance and behavioral addictions. CNS Spectr 11(12):924-930
31. Gruber SA, Silveri MM et al (2007) Neuropsychological consequences of opiate use. Neuropsychol Rev 17(3):299-315
32. Hatsukami DK, Mitchell JE et al (1986) Effect of naltrexone on mood and cognitive functioning among overweight men. Biol Psychiatry 21(3):293-300
33. Hepworth R, Mogg K et al (2010) Negative mood increases selective attention to food cues and subjective appetite. Appetite 54(1):134-142
34. Itoh J, Ukai M et al (1994) Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice. J Pharmacol Exp Ther 269(1):15-21
35. Jacobs-Pilipski MJ, Wilfley DE et al (2007) Placebo response in binge eating disorder. Int J Eat Disord 40(3):204-211
36. Jang CG, Lee SY et al (2003) Impaired water maze learning performance in mu-opioid receptor knockout mice. Brain Res Mol Brain Res 117(1):68-72
37. Kennedy DO, Scholey AB et al (2000) The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology (Berl) 151(4):416-423
38. Le Merrer J, Becker JA et al (2009) Reward processing by the opioid system in the brain. Physiol Rev 89(4):1379-1412
39. Leventhal L, Kirkham TC et al (1995) Selective actions of central mu and kappa opioid antagonists upon sucrose intake in sham-fed rats. Brain Res 685(1-2):205-210
40. Marks-Kaufman R, Kanarek RB (1981) Modifications of nutrient selection induced by naloxone in rats. Psychopharmacology (Berl) 74(4):321-324
41. Martin del Campo AF, McMurray RG et al (1992) Effect of 12-hour infusion of naloxone on mood and cognition in normal male volunteers. Biol Psychiatry 32(4):344-353
42. McClure CK, Patrick TE et al (2011) Birth outcomes following self-inflicted poisoning during pregnancy, California, 2000 to 2004. J Obstet Gynecol Neonatal Nurs 40(3):292-301
43. Milner A, McClure R et al (2011) Globalisation and suicide: an empirical investigation in 35 countries over the period 1980-2006. Health Place 17(4):996-1003
44. Milner A, McClure R et al (2012) Socio-economic determinants of suicide: an ecological analysis of 35 countries. Soc Psychiatry Psychiatr Epidemiol 47(1):19-27
45. Mitchell JE, Laine DE et al (1986) Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome. Biol Psychiatry 21(14):1399-1406
46. Mitchell JE, Morley JE et al (1987) High-dose naltrexone therapy and dietary counseling for obesity. Biol Psychiatry 22(1):35-42
47. Napolitano A, Miller SR et al (2012) Prediction of weight loss and weight regain following dietary, lifestyle and pharmacological intervention. Clin Pharmacol Ther 91(6):1027-1034
48. Nathan PJ, Bullmore ET (2009) From taste hedonics to motivational drive: central mu-opioid receptors and binge-eating behaviour. Int J Neuropsychopharmacol 12(7):995-1008
49. Nathan PJ et al (2011a) Multiple-dose safety, pharmacokinetics and pharmacodynamics of the mu-opioid receptor inverse agonist GSK1521498. J Clin Pharmacol. doi: 10.1177/0091270011421785
50. Nathan PJ, O'Neill BV et al (2011b) Opioid receptor modulation of hedonic taste preference and food intake: a single-dose safety, pharmacokinetic, and pharmacodynamic investigation with GSK1521498, a novel μ-opioid receptor inverse agonist. J Clin Pharmacol 52(4):464-474
51. Nathan PJ, O'Neill BV et al (2011c) The effects of the dopamine D3 receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects. Int J Neuropsychopharmacol 1-13
52. Quednow BB, Csomor PA et al (2008) Sensorimotor gating and attentional set-shifting are improved by the mu-opioid receptor agonist morphine in healthy human volunteers. Int J Neuropsychopharmacol 11(5):655-669
53. Rabiner EA, Beaver J et al (2011) Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Mol Psychiatry 16(8):826-835, 785
54. Riba J, Rodriguez-Fornells A et al (2005) Noradrenergic stimulation enhances human action monitoring. J Neurosci 25(17):4370-4374
55. Robbins TW, Arnsten AF (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267-287
56. Rosner S, Hackl-Herrwerth A et al (2010) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev (12):CD001867
57. Sanger DJ, McCarthy PS (1981) Increased food and water intake produced in rats by opiate receptor agonists. Psychopharmacology (Berl) 74(3):217-220
58. Shah J, Wesnes KA et al (2006) Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. Clin Ther 28(9):1308-1317
59. Spiegel TA, Stunkard AJ et al (1987) Effect of naltrexone on food intake, hunger, and satiety in obese men. Physiol Behav 40(2):135-141
60. Striegel-Moore RH, Cachelin FM et al (2001) Comparison of binge eating disorder and bulimia nervosa in a community sample. Int J Eat Disord 29(2):157-165
61. Stunkard A (1990) A description of eating disorders in 1932. Am J Psychiatry 147(3):263-268
62. Stunkard AJ, Wadden TA (1992) Psychological aspects of severe obesity. Am J Clin Nutr 55(2 Suppl):524S-532S
63. Swanson SA, Crow SJ et al (2011) Prevalence and correlates of eating disorders in adolescents: results from the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry 68(7):714-723
64. Ukai M, Watanabe Y et al (2000) Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on spontaneous alternation performance in mice. Eur J Pharmacol 395(3):211-215
65. Wagner JJ, Terman GW et al (1993) Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 363(6428):451-454
66. Will MJ, Franzblau EB et al (2003) Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J Neurosci 23(7):2882-2888
67. Xie CW, Morrisett RA et al (1992) Mu opioid receptor-mediated modulation of synaptic currents in dentate granule cells of rat hippocampus. J Neurophysiol 68(4):1113-1120
68. Yeomans MR, Gray RW (2002) Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 26(6):713-728